Search results
White Hut Holyoke invites patrons to support baby’s recovery from acute myeloid leukemia
The Republican· 5 days agoAshton Conroy, the son of Holyoke Police Officer Crystal Conroy, is courageously battling acute ...
GlycoMimetics downgraded after Phase 3 trial fails to meet endpoint By Investing.com
Investing.com· 7 hours agoGlycoMimetics' uproleselan, a drug candidate for treating relapsed or refractory acute myeloid ...
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 1 day agoThe study aimed to determine the efficacy of uproleselan in improving survival rates when used...
Earnings call: Kura Oncology reports on ziftomenib's progress By Investing.com
Investing.com· 1 day agoZiftomenib has received Breakthrough Therapy designation from the FDA for the treatment of...
...for Treatment of Adenoid Cystic Carcinoma (ACC) and Acute Myeloid Leukemia/Myelodysplastic...
CBS 47 Fresno· 5 days agoAdditionally, the company also announced that REM-422 has received Orphan Drug Designation from the FDA for the treatment of ACC and AML...
Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of...
The Pilot News· 1 day agoDeerfield Management and the Deerfield Foundation announced today they will honor the 2023-2024 recipients of the American Society of Hematology (ASH) Peter Steelman Scholar Award at the second ...
New approach for developing cancer vaccines could make immunotherapies more effective in acute ...
Medical Xpress· 4 days agoIn a new study published in Blood Advances, researchers from the UChicago Pritzker School of...
CD7 expression tied to poorer outcomes with newly diagnosed leukemia
Medical Xpress· 3 days agoCD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid ...
Testing for residual cancer cells before blood cell transplant therapy is important and practical,...
Medical Xpress· 5 days ago"The good news is this testing is doable," said Christopher Hourigan, a Virginia Tech professor of...
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
Morningstar· 1 day agoTC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today ...